Laser-assisted phototherapy clears AK in immunocompromised patients

05/28/2013 | SkinAndAllergyNews.com

Intensified ablative fractional laser-assisted photodynamic therapy cleared actinic keratoses and warty lesions on the hands of organ-transplant recipients better than blative fractional laser therapy alone in a randomized clinical trial. Ablative fractional laser-assisted photodynamic therapy was painful and caused intense inflammation in 30% of patients, but completely cleared 73% of all actinic keratoses and 37% of all wartlike lesions, compared with 31% and 14% respectively, for ablative fractional laser alone.

View Full Article in:

SkinAndAllergyNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC